Kingworld Medicines Group Limited (HKG:1110)
Hong Kong · Delayed Price · Currency is HKD 0.5300
-0.0100 (-1.89%)
Sep 8, 2025, 3:55 PM HKT
Kingworld Medicines Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 41.56 | 38.1 | 22.74 | 30.32 | 11.72 | Upgrade |
Depreciation & Amortization | 20.15 | 20.08 | 38.19 | 34.78 | 34.54 | Upgrade |
Loss (Gain) From Sale of Assets | 0.34 | 0.21 | 0.05 | 1.3 | 0.12 | Upgrade |
Asset Writedown & Restructuring Costs | -3.93 | 1.36 | 7.3 | -0.8 | 1.6 | Upgrade |
Loss (Gain) From Sale of Investments | 4.25 | -12.94 | -2.89 | -0.47 | 3.36 | Upgrade |
Loss (Gain) on Equity Investments | -19.1 | -8.6 | -7.64 | -8.99 | -12.4 | Upgrade |
Stock-Based Compensation | 3.61 | 1.96 | 0.73 | - | - | Upgrade |
Provision & Write-off of Bad Debts | 0.2 | 0.44 | 1.04 | 0.05 | 0.96 | Upgrade |
Other Operating Activities | 37.31 | 33 | 33.77 | 40.26 | 67.95 | Upgrade |
Change in Accounts Receivable | -5.22 | 30.2 | 50.07 | -11.5 | 67.13 | Upgrade |
Change in Inventory | 0.33 | -41.15 | 21.47 | 16.51 | 41.34 | Upgrade |
Change in Accounts Payable | 10.31 | 49.55 | 35.92 | -35.5 | -85.42 | Upgrade |
Change in Unearned Revenue | 2.72 | -0.37 | -14.19 | 15.23 | -15.85 | Upgrade |
Change in Other Net Operating Assets | 43.29 | -69.55 | - | - | 8.55 | Upgrade |
Operating Cash Flow | 135.82 | 42.28 | 186.55 | 81.2 | 123.58 | Upgrade |
Operating Cash Flow Growth | 221.21% | -77.33% | 129.74% | -34.30% | -6.88% | Upgrade |
Capital Expenditures | -41.09 | -105.54 | -93.51 | -58.32 | -9.93 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.02 | 0.11 | 1.57 | - | Upgrade |
Sale (Purchase) of Real Estate | - | -7.48 | - | - | - | Upgrade |
Investment in Securities | 5.09 | -44.16 | -3 | -4.88 | -10 | Upgrade |
Other Investing Activities | 8.36 | 36.52 | 12.35 | 10.8 | 17.17 | Upgrade |
Investing Cash Flow | -27.64 | -120.63 | -84.05 | -50.84 | -2.76 | Upgrade |
Short-Term Debt Issued | - | - | - | 124.68 | 421.87 | Upgrade |
Long-Term Debt Issued | 436.15 | 327.51 | 373.37 | - | - | Upgrade |
Total Debt Issued | 436.15 | 327.51 | 373.37 | 124.68 | 421.87 | Upgrade |
Short-Term Debt Repaid | - | - | - | -187.18 | -330.9 | Upgrade |
Long-Term Debt Repaid | -398.41 | -267.16 | -348.16 | -8.15 | -9.58 | Upgrade |
Total Debt Repaid | -398.41 | -267.16 | -348.16 | -195.33 | -340.48 | Upgrade |
Net Debt Issued (Repaid) | 37.74 | 60.34 | 25.21 | -70.65 | 81.39 | Upgrade |
Issuance of Common Stock | - | - | - | 2.46 | - | Upgrade |
Repurchase of Common Stock | -4.81 | -8.71 | -5.04 | - | -7.03 | Upgrade |
Common Dividends Paid | -19.78 | -13.92 | -13.29 | -3.3 | -12.27 | Upgrade |
Other Financing Activities | -60.77 | -33.34 | -58.19 | -15.7 | -37.06 | Upgrade |
Financing Cash Flow | -47.61 | 4.37 | -51.31 | -87.2 | 25.03 | Upgrade |
Foreign Exchange Rate Adjustments | 1.05 | 5.5 | 3.04 | -6.06 | -8.53 | Upgrade |
Net Cash Flow | 61.62 | -68.48 | 54.23 | -62.89 | 137.32 | Upgrade |
Free Cash Flow | 94.73 | -63.25 | 93.04 | 22.88 | 113.66 | Upgrade |
Free Cash Flow Growth | - | - | 306.62% | -79.87% | -8.28% | Upgrade |
Free Cash Flow Margin | 8.93% | -5.86% | 9.71% | 2.70% | 15.25% | Upgrade |
Free Cash Flow Per Share | 0.16 | -0.11 | 0.15 | 0.04 | 0.18 | Upgrade |
Cash Interest Paid | 13.28 | 11.52 | 12.29 | 11.78 | 15.43 | Upgrade |
Cash Income Tax Paid | 21.19 | 30.48 | 22.13 | 14.8 | 23.01 | Upgrade |
Levered Free Cash Flow | 88.36 | -64.91 | 87.37 | 10.66 | 106.39 | Upgrade |
Unlevered Free Cash Flow | 96.66 | -57.71 | 95.05 | 18.03 | 115.87 | Upgrade |
Change in Working Capital | 51.43 | -31.31 | 93.26 | -15.25 | 15.75 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.